Literature DB >> 2542318

Functional domains of vaccinia virus mRNA capping enzyme. Analysis by limited tryptic digestion.

S Shuman1.   

Abstract

RNA triphosphatase, RNA guanylyltransferase, RNA (guanine-7)-methyltransferase, and transcription termination factor activities are associated with the mRNA capping enzyme from vaccinia virus. Purified vaccinia capping enzyme is a 6.5 S protein containing two subunits of Mr = 95,000 and Mr = 31,000. Although the RNA guanylyltransferase domain has been localized to the large subunit by virtue of the formation of a Mr = 95,000 covalent protein-GMP intermediate, the location of other functional domains within the protein and the catalytic role of individual subunits remain unclear. In the present study, limited proteolysis with trypsin was shown to convert the vaccinia capping enzyme into a form capable of generating a Mr = 59,000 enzyme-GMP complex. Purification of the trypsinized enzyme by glycerol gradient sedimentation resulted in the isolation of a 4.2 S fragment of the large subunit that retains RNA triphosphatase and RNA guanylyltransferase activities. This derivative, containing little or no small subunit (or fragments thereof), has lost the ability to catalyze methyl group transfer and to mediate transcription termination in vitro. Residual methyltransferase activity was found associated with a minor 5.2 S tryptic product that cosediments with a Mr = 21,000 fragment of the small enzyme subunit. A model for the organization of functional domains within the capping enzyme is suggested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542318

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution.

Authors:  M S Carpenter; A M DeLange
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.

Authors:  Marcos De la Peña; Otto J P Kyrieleis; Stephen Cusack
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

3.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

4.  A yeast-based genetic system for functional analysis of viral mRNA capping enzymes.

Authors:  C K Ho; A Martins; S Shuman
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Crystal structure of vaccinia virus mRNA capping enzyme provides insights into the mechanism and evolution of the capping apparatus.

Authors:  Otto J P Kyrieleis; Jonathan Chang; Marcos de la Peña; Stewart Shuman; Stephen Cusack
Journal:  Structure       Date:  2014-03-04       Impact factor: 5.006

6.  Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme.

Authors:  L Yu; A Martins; L Deng; S Shuman
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  The D1 and D12 subunits are both essential for the transcription termination factor activity of vaccinia virus capping enzyme.

Authors:  Y Luo; X Mao; L Deng; P Cong; S Shuman
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

8.  Mutational analysis of the RNA triphosphatase component of vaccinia virus mRNA capping enzyme.

Authors:  L Yu; S Shuman
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Expression of Semliki Forest virus nsP1-specific methyltransferase in insect cells and in Escherichia coli.

Authors:  P Laakkonen; M Hyvönen; J Peränen; L Kääriäinen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

10.  Mutational analysis of vaccinia virus mRNA cap (guanine-N7) methyltransferase reveals essential contributions of the N-terminal peptide that closes over the active site.

Authors:  Sushuang Zheng; Stewart Shuman
Journal:  RNA       Date:  2008-09-17       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.